Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Head & Neck 2Other hematologic neoplasm 1Other 1Genitourinary 1Dermatologic 1Breast 1

Conditions

Psychotic Disorders 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neuralgia 1Lymphoma, Follicular 1Bipolar Disorder 1

Interventions

Rituximab 689Cyclophosphamide 614Vincristine 285Etoposide 272Doxorubicin 271Cytarabine 230Prednisone 228Methotrexate 221fludarabine phosphate 189Filgrastim 187Dexamethasone 180fludarabine 175Lenalidomide 165Radiotherapy 128Melphalan 127Peripheral Blood Stem Cell Transplantation 123Busulfan 118Bendamustine Hydrochloride 116Granulocyte Colony-Stimulating Factor 113Bortezomib 112ibrutinib 111Mycophenolic Acid 110venetoclax 106Whole-Body Irradiation 106Tacrolimus 105obinutuzumab 104Gemcitabine 92zanubrutinib 81Specimen Handling 80Cyclosporine 76

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Gabapentin × Lymphoid × Clear all
NCT05064319 2025-07-08

Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders

Medical University of South Carolina

Phase 2 Recruiting
68 enrolled
Lymphoid

Bipolar Disorder, Lymphoma, Follicular, Psychotic Disorders

NCT01506453 2019-06-19

TINALL

St. Jude Children's Research Hospital

Phase 2 Completed
51 enrolled 7 charts
LymphoidOther hematologic neoplasm

Neuralgia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡